Voluntary Information Disclosure of Pharmaceutical Industries in Bangladesh

UIU Institutional Repository

    • Login
    View Item 
    •   UIU DSpace Home
    • School of Business and Economics (SoBE)
    • Business Administration (BBA)
    • Project Report (BBA)
    • Accounting
    • View Item
    •   UIU DSpace Home
    • School of Business and Economics (SoBE)
    • Business Administration (BBA)
    • Project Report (BBA)
    • Accounting
    • View Item
    JavaScript is disabled for your browser. Some features of this site may not work without it.

    Voluntary Information Disclosure of Pharmaceutical Industries in Bangladesh

    Thumbnail
    View/Open
    Final.docx (107.0Kb)
    Date
    2020-11-23
    Author
    Jahan, Nusrat
    Metadata
    Show full item record
    Abstract
    This report is about voluntary information disclosure of pharmaceutical industries in Bangladesh. It includes the details discussion of six voluntary disclosure items of annual report. For this report nine pharmaceutical companies were chosen and those are, Square Pharmaceutical Limited, Beximco Pharma, Orion Infusion Limited, Renata Limited, Delta Pharmaceutical Limited, ACME Laboratories Limited, Advent Pharma Limited, Beacon Pharmaceutical Limited and Far Chemical Industries Limited. Among these companies Square holds the 1st position among all the pharmaceutical companies in Bangladesh. To get a better idea of the extent of the voluntary disclosure items reported in the annual report (Square, Beximco, Renata, ACME, Beacon, Advent) top ranked, (Orion Pharma) medium ranked and (Delta Pharma) low ranked company were chosen. This would provide the overall picture of how much information voluntarily disclosed in annual report of pharmaceutical companies. For this reason, data has been collected from the annual report of these companies. The financial year 2018-2019 were selected for all companies for this project. In this particular year, how much information is voluntarily shown along with the mandatory information by these companies were analyzed. Finally, the details findings of the voluntary disclosure items in annual report regarding this nine pharmaceutical companies are outlined throughout the report at the later part.
    URI
    http://dspace.uiu.ac.bd/handle/52243/1955
    Collections
    • Accounting [252]

    Copyright 2003-2017 United International University
    Contact Us | Send Feedback
    Developed by UIU CITS
     

     

    Browse

    All of DSpaceCommunities & CollectionsBy Issue DateAuthorsTitlesSubjectsThis CollectionBy Issue DateAuthorsTitlesSubjects

    My Account

    LoginRegister

    Copyright 2003-2017 United International University
    Contact Us | Send Feedback
    Developed by UIU CITS